Although tafazzin-deficient hearts exhibit CL alterations similar to BTHS patients (i.e. high MLCL/CL ratio), it is important to underlie that TazKD mice present relatively mild and late-onset cardiomyopathy phenotypes31,33–35. The gene discussed is TAFAZZIN; the disease is Barth syndrome.